ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD64 Antibody [B-T44] - BSA and Azide free (A342121)

Mouse monoclonal [B-T44] IVD antibody to CD64 for Flow Cytometry.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-CD64 Antibody [B-T44] - BSA and Azide free
Description
Mouse monoclonal [B-T44] IVD antibody to CD64.
Specificity
Recognize natural and recombinant human CD64.
Applications
Flow Cytometry
Reactivity
Human
Immunogen
Recombinant Human CD64.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-T44
Myeloma
Source: Myeloma X63/AG.8653 x Balb/c lymph nodes cells
Isotype
Mouse IgG2b Kappa light chain
Conjugate

Unconjugated

Concentration
1.0 mg/mL (+/- 10 %)
Product Form
Liquid
Formulation
Phosphate-buffered saline. Sterile-filtered through 0.22µm. Carrier and preservative free.
Storage
Store at + 4°C. Stable for 12 months. Do Not Freeze this product!
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
Fc gamma receptor IB pseudogene, Fc-gamma RI, Fc-gamma RIA, Fc-gamma RIB, FCG1, FcgammaRIa, FCGR1, FCGR1A, FCGR1B, FCGR1BP, FcRI, FcRIB, hFcgammaRIB, High affinity immunoglobulin gamma Fc receptor I, IGFR1, IGFRB, IgG Fc receptor I, IgG Fc receptor IB, Putative high affinity immunoglobulin gamma Fc receptor IB
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD64 Antibody [B-T44] - BSA and Azide free (A342121)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD64 Antibody [B-T44] - BSA and Azide free (A342121)

Proteins predicted to interact with CD64

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
98.9% Relevancy Score
98.7% Relevancy Score
98.6% Relevancy Score
98.5% Relevancy Score
96% Relevancy Score
94.9% Relevancy Score
94.3% Relevancy Score
93.9% Relevancy Score
92.1% Relevancy Score